Get access

Oral antifungal medication for toenail onychomycosis

  • Protocol
  • Intervention

Authors

  • Sanne Kreijkamp-Kaspers,

    Corresponding author
    1. The University of Queensland, Discipline of General Practice, School of Medicine, Brisbane, Herston, Queensland, Australia
    • Sanne Kreijkamp-Kaspers, Discipline of General Practice, School of Medicine, The University of Queensland, Level 8, Health Sciences Building 16/910, Royal Brisbane & Women's Hospital Complex, Brisbane, Herston, Queensland, 4029, Australia. s.kreijkampkaspers@uq.edu.au.

    Search for more papers by this author
  • Sally EM Bell-Syer,

    1. University of York, Department of Health Sciences, York, North Yorkshire, UK
    Search for more papers by this author
  • Parker Magin,

    1. The University of Newcastle, Discipline of General Practice, School of Medicine and Public Health, Callaghan, Australia
    Search for more papers by this author
  • Sophie V Bell-Syer,

    1. Keele University, Keele University Medical School, Keele, Staffordshire, UK
    Search for more papers by this author
  • Mieke L van Driel

    1. The University of Queensland, Discipline of General Practice, School of Medicine, Brisbane, Herston, Queensland, Australia
    Search for more papers by this author

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To compare the benefits and harms of oral antifungal treatments for toenail onychomycosis.

Ancillary